RHHBY:OTCMKTS
Roche Holdings AG Basel ADR Common Stock
$53.37
arrow_downward
-1.98%(-1.08) 1D
$53.36
arrow_downward
-0.02% (-0.0094)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHBY...
Open
$53.35
High
$53.62
Low
$53.08
Mkt. cap
347.25B
Avg. vol.
2.01M
Volume
2.79M
P/E ratio
23.07
52-wk high
$60.85
52-wk low
$39.78
EPS
$2.31
Beta
0.45
Shares outstanding
5.62B
No. of employees
113K
Open
$53.35
High
$53.62
Low
$53.08
Mkt. cap
347.25B
Avg. vol.
2.01M
Volume
2.79M
P/E ratio
23.07
52-wk high
$60.85
52-wk low
$39.78
EPS
$2.31
Beta
0.45
Shares outstanding
5.62B
No. of employees
113K
News stories
From web sources and news partners
Stock Titan
·
6 hours ago
An Oregon plant expansion will create about 250 high-wage manufacturing jobs
Seeking Alpha
·
9 hours ago
Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Key Therapeutic Areas - Slideshow (OTCMKTS:RHHBY) 2026-09-28
Euronext Markets: Real-time Stock Market Data | live
·
14 hours ago
Roche outlines plans to move towards autonomous AI labs
WSJ
·
15 hours ago
Roche Halts Development of Obesity Drug Candidate
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holdings AG Basel ADR Common Stock
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com